MEMORANDUM OPINION
TANNENWALD,
This case has been submitted under Rule 122, and1989 Tax Ct. Memo LEXIS 165">*168 all of the facts have been stipulated. The stipulation of fact and the attached exhibits are incorporated herein by reference.
Petitioners resided in Scarsdale, New York, at the time of the filing of their petition. Catherine K. Ware is a party to this proceeding solely by reason of having filed a joint Federal income tax return with her husband. All further references to petitioner are to R. Timmis Ware.
Petitioner is an attorney licensed to practice in New York. He was a partner in the law firm of Rogers, Hoge & Hills (RH & H) from 1972 until his withdrawal on December 31, 1981. James B. Swire was also a partner in the same law firm from 1974 until December 31, 1981.
From January through August 1981, petitioner and Mr. Swire provided advice to Pharmachemical Industries Incorporated (Pharmachemical) and its subsidiary Pilmar Pharmachemicals Limited (Pilmar) relating to the sale of an Irish pharmaceutical plant owned and operated by Pilmar. During this period of time, they solicited potential buyers of the plant; in so doing, they conducted all the activities relating to the location of a purchaser with the use of RH & H's facilities, personnel, communications and office1989 Tax Ct. Memo LEXIS 165">*169 equipment, and other resources of the firm without the knowledge or consent of RH & H. The efforts of petitioner and Mr. Swire culminated in the sale of the Irish pharmaceutical plant on August 12, 1981, and a fee was paid pursuant to a prior arrangement with Pharmachemical, the details of which are not relevant herein. However, the fee was paid to and held in escrow by one Thomas S. Figgis until its disbursement in January 1982.
From and after June 1981, there was a dispute between RH & H, on the one hand, and petitioner and Mr. Swire, on the other, as to who was entitled to the fee. On January 15, 1982, after extensive negotiations, the dispute was settled. Petitioner, Mr. Swire, and RH & H reached an agreement (withdrawal agreement) whereby the respective rights in the fee were settled and petitioner and Mr. Swire withdrew from the law firm as of December 31, 1981. The withdrawal agreement provided:
2. With respect to periods ending on or prior to December 31, 1981, each of the Partners shall be entitled to receive those amounts which he would have been entitled to receive under the Partnership Agreement and the notice issued by the Senior Partners pursuant thereto had1989 Tax Ct. Memo LEXIS 165">*170 that Partner died on December 31, 1981, except for any sums which may be attributable to any income received by the Firm subsequent to December 31, 1981 pursuant to paragraph 4 of this agreement, but including, without limitation:
(a) the amount of that Partner's interest in the working capital account at December 31, 1981;
(b) the amount of that Partner's interest in the income account for the year ended December 31, 1981 at the percentages designated in a notice dated December 1, 1980 for the Senior Partners (4.7376% in the case of Swire and 4.9798% in the case of Ware);
(c) an amount equal to Five Thousand Dollars ($ 5,000.00) times that Partner's share of excess over quota as set forth in the notice dated December 1, 1980 from the Senior Partners (4.7376% in the case of Swire and 4.9798% in the case of Ware);
(d) the amount of that Partner's share of the fees and disbursements of the Firm's counsel in connection with the subject matter of this agreement paid in 1981 (4.7376% in the case of Swire and 4.9798% in the case of Ware).
* * *
4. Attached as Exhibit A is a computation of the net fee received in connection with the sale of the assets of the Pilmar * * * (the1989 Tax Ct. Memo LEXIS 165">*171 "Net Net Fee"). The Net Fee was determined by increasing the total fee received by the interest thereon and reduced by the legal fee of Irish counsel and the other expenses of Swire and Ware all as more particularly set forth on Exhibit A attached hereto. The Partners will pay to the Firm one-half of the Net Fee.
5. There will be a closing (the "Closing") of this Agreement at such time as the funds of the Net Fee are available for delivery to the Firm, but no later than January 22, 1982. At the closing, the Partners shall pay to the Firm one-half of the Net Fee as determined in paragraph 4 and Exhibit A hereto. At the Closing, the Firm shall pay to Swire and Ware on account of the sums which they are entitled to receive under paragraph 2 hereof the following:
(a) With respect to the amount of that Partner's interest in the working capital account December 31, 1981, the sum of $ 13,200.00 in the case of Swire and the sum of $ 13,875.00 in the case of Ware, which sums represent the amount of such Partners' respective interest in the working capital account at December 31, 1981.
(b) With respect to the amount of that Partner's interest in the income account for the year ended1989 Tax Ct. Memo LEXIS 165">*172 December 31, 1981, the sum of $ 12,862.40 in the case of Swire and the sum of $ 13,520.20 in the case of Ware, which sums represent the estimated unpaid balance of quota for 1981. * * *
(c) With respect to the amount payable under paragraph 2(c) hereof, the sum of $ 23,688.00 in the case of Swire and the sum of $ 24,899.00 in the case of Ware.
(d) With respect to the amount payable under paragraph 2(d), the sum of $ 922.49 in the case of Swire and the sum of $ 969.65 in the case of Ware.
An attachment to the withdrawal agreement reflected that the total net fee was $ 381,226.57. Pursuant to the withdrawal agreement, petitioner and Mr. Swire each were entitled to one-fourth of the net fee ($ 95,306.64), and RH & H was entitled to the other half of the fee ($ 190,613.28). On or about January 19, 1982, Mr. Figgis was instructed to release $ 86,676.54 of the fee to RH & H and the balance of $ 294,550.02 to petitioner and Mr. Swire. 3
The withdrawal agreement1989 Tax Ct. Memo LEXIS 165">*173 also provided that petitioner and Mr. Swire were to be non-participating contract partners in the law firm from January 1, 1982, to March 31, 1982. The withdrawal agreement stated that petitioner was to receive a monthly salary of $ 5,775 as consideration for his services.
Petitioner reported ordinary income of $ 42,224 received from RH & H on Schedule E, Supplemental Income Schedule, of his 1982 Federal income tax return. This amount represented the $ 17,325 compensation received by petitioner for remaining with RH & H on a non-participating basis from January 1, 1982, until March 31, 1982, and the $ 24,899 received as payment for his income interest under paragraphs 2(c) and 5(c) of the withdrawal agreement. Petitioner reported a long-term capital gain of $ 77,982 on Schedule D, Capital Gains and Loss, representing payments received upon his withdrawal from RH & H. Petitioner calculated this gain as follows:
Working Capital Account | $ 13,875 |
Income Account (Estimated Unpaid | |
Balance of Quota) | 13,520 |
$ 5,000 x shares of excess over quota | 24,899 |
Distribution | 95,307 |
Total | $ 147,601 |
Less K-1 Amount | 42,224 |
Gross Selling Price | $ 105,377 |
Less Adjusted Basis | 27,395 |
Total Gain Reported | $ 77,982 |
1989 Tax Ct. Memo LEXIS 165">*174 Respondent's Explanation of Adjustments to the Statutory Notice of Deficiency, issued on November 20, 1986, states in pertinent part:
During the tax year ended December 31, 1982, $ 95,307.00 of income that you received from Pharmachemical Industries Incorporated was improperly treated by you as part of the proceeds from the sale (redemption) of your interest in the law firm of Rogers Hoge and Hills. Furthermore, during the tax year ended December 31, 1982, $ 17,325.00 of the combined proceeds of your sale of your interest in the law firm of Rogers Hoge and Hills and the income you received from Pharmachemical Industries Incorporated was not reported on your return.
Accordingly, your taxable income is increased $ 64,114.00 for the tax year ended December 31, 1982, calculated, as follows:
Fee from Pharmachemical Industries | ||
Incorporated (Ordinary Income) | $ 95,307.00 | |
Proceeds from Sale (Redemption) | ||
of interest in Rogers Hoge & Hill | $ 27,395.00 | |
Less: Adjusted Basis | (27,395.00) | |
Gain on Sale (Redemption)(Long Term) | -0- | |
IRC § 1202 deduction | -0- | |
Taxable gain on Sale (Redemption) | -0- | |
Combined income from fee and sale (redemption) | $ 95,307.00 | |
Less: Amount per return | (31,193.00) | |
Adjustment | $ 64,114.00 |
1989 Tax Ct. Memo LEXIS 165">*175 Preliminarily, we must dispose of certain contentions of the parties which, for the most part, involve procedural issues. In his deficiency notice, respondent only determined that the $ 95,307 fee and the $ 17,325 compensation from RH & H in 1982 constituted income of petitioner. 4 Respondent now seeks to have us hold that the " capital account" item ($ 13,875) and the "income account" item ($ 13,520), both items aggregating the $ 27,395 which respondent initially included in income and then allowed as an offset by way of "adjusted basis," should be held to be income of petitioner without any offset as guaranteed payments under section 736(a)(2). Respondent, however, neither amended his answer, or otherwise pleaded, to raise any issue as to these amounts, nor did he claim any increased deficiency other than to assert on brief that his determination "except as modified herein, should be sustained." Clearly, if we were to hold that the two items in question were income of petitioner without offset and also sustain respondent's determination as to the $ 95,307, our holding would be a futile act unless we were to hold that the amount of the deficiency should be increased beyond the1989 Tax Ct. Memo LEXIS 165">*176 amount determined in the deficiency notice. However, an increased deficiency must be claimed at or before the hearing.
1989 Tax Ct. Memo LEXIS 165">*177 The principal issue involved herein is the proper treatment of the $ 95,307 received by petitioner as his share of the Pharmachemical transaction fee pursuant to paragraph 4 of the withdrawal agreement. Petitioner asserts that the total fee is attributable to RH & H, that the payment of his share of the fee represents a portion of the amount paid to him on a sale of his partnership interest, and that he properly characterized the proceeds as capital gain under
Seizing upon what might be described as the shifting sands of respondent's arguments, petitioner characterizes respondent's position on brief as raising a new issue, which the Court should disregard or as to which, at1989 Tax Ct. Memo LEXIS 165">*178 least, should place the burden of proof upon respondent. We find it unnecessary to deal with petitioner's procedural contention because we conclude, upon the basis of the record before us, that respondent should prevail irrespective of the location of the burden of proof.
We reach our conclusion under
In the case of a sale or exchange of an interest in a partnership, gain or loss shall be recognized to the transferor partner. Such gain or loss shall be considered as gain or loss from the sale or exchange of a capital asset, except as otherwise provided in
Thus, if we assume solely for purposes of decision herein that the transaction between petitioner and RH & H constituted a sale of petitioner's partnership interest, we are left with the question whether the $ 95,307 paid to petitioner in respect of the Pharmachemical1989 Tax Ct. Memo LEXIS 165">*179 transaction fee constitutes an amount received by petitioner attributable to an unrealized receivable of the partnership as provided in
The long and the short of the matter is that the Pharmachemical transaction fee was an unrealized receivable of RH & H in respect of which petitioner received a payment of $ 95,307 in the taxable year before us. Consequently, that payment is taxable to him as ordinary income under
Respondent also determined that there was a substantial understatement of income tax and that petitioner was, therefore, subject to an addition to tax equal to 10 percent of the underpayment attributable to such understatement pursuant to
1. Unless otherwise indicated, all section references are to the Internal Revenue Code as amended and in effect during the year in issue, and all Rule references are to the Tax Court Rules of Practice and Procedure. ↩
2. We note that the statutory notice of deficiency is based on this figure, while petitioner occasionally uses $ 95,306. We adopt the figure used in the statutory notice of deficiency.↩
3. The portion of RH & H's one-half share of the full $ 190,613.28 was reduced by the payments ($ 53,263.85 to petitioner and $ 50,673.09 to Mr. Swire) required by other provisions of the withdrawal agreement.↩
4. Respondent has now stipulated that the $ 17,325 item was reported by petitioner as ordinary income in 1982, so this amount is no longer at issue. ↩
5. See also
6. Neither the partnership return nor petitioner's K-1 for 1982 are in the record.↩
7. We think it of interest that the three cited cases were extensively discussed in respondent's opening brief but totally ignored by petitioner in both his opening and reply briefs.↩